The DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index.
Delivery materials for siRNA therapeutics
Abstract
RNA interference (RNAi) has broad potential as a therapeutic to reversibly silence any gene. To achieve the clinical potential of RNAi, delivery materials are required to transport short interfering RNA (siRNA) to the site of action in the cells of target tissues. This Review provides an introduction to the biological challenges that siRNA delivery materials aim to overcome, as well as a discussion of the way that the most effective and clinically advanced classes of siRNA delivery systems, including lipid nanoparticles and siRNA conjugates, are designed to surmount these challenges. The systems that we discuss are diverse in their approaches to the delivery problem, and provide valuable insight to guide the design of future siRNA delivery materials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several miRNAs and antisense oligonucleotides (ASOs) are currently under investigation in clinical trials for various diseases (Kanasty et al., 2013;van Rooij and Kauppinen, 2014;Gaudet et al., 2015).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Kanasty et al., 2013
In the citing paper
“The main role of PEGylated lipid in LNPs is to reduce aggregation and non-specific uptake by immune cells.304–306”
From Advances in COVID-19 mRNA vaccine development (2022) · cites this paper as [306]
In the citing paper
“we believe that recent advances in the delivery of nucleic acid therapeutics provide hope that CRISPR-Cas9–mediated correction may be translatable to humans15.”
From Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype (2014) · cites this paper as [15]
Citations
Cites
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,833
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,651
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationAsymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,541
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Phenotypic Heterogeneity of the Endothelium
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,824
Flagged first, then by citations
1 of the 113 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,002
Zhao, Z., Ukidve, A., Gao, Y., Kim, J., & Mitragotri, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9250 · Cited by 152
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
Hattab, D., Gazzali, A. M., & Bakhtiar, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071009 · Cited by 154
Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics
Shen, J., Zhang, W., Qi, R., Mao, Z., & Shen, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00479f · Cited by 149
Remote loading of preencapsulated drugs into stealth liposomes
Sur, S., Fries, A. C., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324135111 · Cited by 154
Chemical and structural modifications of RNAi therapeutics
Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K., & Kim, S. H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.015 · Cited by 146
Fernández‐Santos, M. E., García‐Arranz, M., Andreu, E. J., García-Hernández, A. M., López-Parra, M., Villarón, E. M., Sepúlveda, P., Fernández‐Avilés, F., García‐Olmo, D., Prósper, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918565 · Cited by 147
Alameh, M., Lavertu, M., Tran‐Khanh, N., Chang, C., Lesage, F., Bail, M., Darras, V., Chevrier, A., & Buschmann, M. D. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01297 · Cited by 142
Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor
Xiao, Y., Shi, K. Y., Qu, Y., Chu, B., & Qian, Z. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.09.002 · Cited by 144
Sutaria, D. S., Badawi, M., Phelps, M. A., & Schmittgen, T. D. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2123-5 · Cited by 140
Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications
Barba, A. A., Bochicchio, S., Dalmoro, A., & Lamberti, G. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080360 · Cited by 147
Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA
Warren, M. R., Zhang, C., Vedadghavami, A., Bokvist, K. B., Dhal, P. K., & Bajpayee, A. G. (2020) · Biomaterials Science · doi:10.1039/d0bm01497d · Cited by 140
Lee, S. M., Cheng, Q., Yu, X., Liu, S., Johnson, L. T., & Siegwart, D. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202013927 · Cited by 142
α-Globin as a molecular target in the treatment of β-thalassemia
Mettananda, S., Gibbons, R. J., & Higgs, D. R. (2015) · Blood · doi:10.1182/blood-2015-03-633594 · Cited by 144
Major degradable polycations as carriers for DNA and siRNA
Islam, M. A., Park, T., Singh, B., Maharjan, S., Firdous, J., Cho, M., Kang, S., Yun, C., Choi, Y., & Cho, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.055 · Cited by 139
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives
Stuppia, G., Rizzo, F., Riboldi, G. M., Bo, R. D., Nizzardo, M., Simone, C., Comi, G. P., Bresolin, N., & Corti, S. P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.033 · Cited by 138
Wang, M., Thomas, N. C., & Jin, H. (2017) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2017.05.003 · Cited by 143
Saw, P. E., Yao, H., Lin, C., Tao, W., Farokhzad, O. C., & Xu, X. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01660 · Cited by 138
Smart pH-responsive nanomedicines for disease therapy
Shinn, J., Kwon, N., Lee, S. A., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00573-z · Cited by 140
Nanomaterials for Therapeutic RNA Delivery
Han, X., Mitchell, M. J., & Nie, G. (2020) · Matter · doi:10.1016/j.matt.2020.09.020 · Cited by 139
Park, T., Singh, B., Li, H.-S., Lee, J.-Y., Kang, S., Choi, Y., & Cho, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.068 · Cited by 134
Li, S., Saw, P. E., Lin, C., Nie, Y., Tao, W., Farokhzad, O. C., Zhang, L., & Xu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119760 · Cited by 133
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
Ly, S., Navaroli, D. M., Didiot, M.-C., Cardia, J., Pandarinathan, L., Alterman, J. F., Fogarty, K., Standley, C., Lifshitz, L. M., Bellve, K. D., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1005 · Cited by 132
Qian, C., Zhu, S., Feng, P., Chen, Y., Yu, J., Tang, X., Liu, Y., & Shen, Q. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04987 · Cited by 133
Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth
Rahman, M. A., Wang, P., Zhao, Z., Wang, D., Nannapaneni, S., Zhang, C., Chen, Z., Griffith, C. C., Hurwitz, S. J., Chen, Z. G., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201709485 · Cited by 132
Bioinspired Core–Shell Nanoparticles for Hydrophobic Drug Delivery
Yang, G., Liu, Y., Wang, H., Wilson, R. J., Hui, Y., Yu, L., Wibowo, D., Zhang, C., Whittaker, A. K., Middelberg, A. P. J., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908357 · Cited by 132
Nanoplatforms for mRNA Therapeutics
Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000099 · Cited by 130
mRNA nanomedicine: Design and recent applications
Kubiatowicz, L. J., Mohapatra, A., Krishnan, N., Fang, R. H., & Zhang, L. (2022) · Exploration · doi:10.1002/exp.20210217 · Cited by 131
Lipid carriers for mRNA delivery
Zhang, W., Jiang, Y., He, Y., Boucetta, H., Wu, J., Chen, Z., & He, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.026 · Cited by 134
Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease
de Bruin, R. G., Rabelink, T. J., van Zonneveld, A. J., & van der Veer, E. P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw567 · Cited by 133
Wang, L. L., Chung, J. J., Li, E. C., Uman, S., Atluri, P., & Burdick, J. A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.004 · Cited by 129
Zhang, Q., Kuang, G., He, S., Lu, H., Cheng, Y., Zhou, D., & Huang, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04981 · Cited by 129
microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain
Kim, J., Yoon, H., Horie, T., Burchett, J. M., Restivo, J. L., Rotllan, N., Ramírez, C. M., Verghese, P. B., Ihara, M., Hoe, H.-S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2053-15.2015 · Cited by 128
“Several miRNAs and antisense oligonucleotides (ASOs) are currently under investigation in clinical trials for various diseases (Kanasty et al., 2013; van Rooij and Kauppinen, 2014; Gaudet et al., 2015).”
BackgroundMöller, K., Müller, K., Engelke, H., Bräuchle, C., Wagner, E., & Bein, T. (2015) · Nanoscale · doi:10.1039/c5nr06246b · Cited by 133
Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy
Xu, X., Saw, P. E., Tao, W., Li, Y., Ji, X., Yu, M., Mahmoudi, M., Rasmussen, J., Ayyash, D., Zhou, Y., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01571 · Cited by 128
Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
Fenton, O. S., Kauffman, K. J., McClellan, R. L., Kaczmarek, J. C., Zeng, M. D., Andresen, J. L., Rhym, L. H., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201809056 · Cited by 129
Self-citationDNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
Nishina, K., Piao, W., Yoshida‐Tanaka, K., Sujino, Y., Nishina, T., Yamamoto, T., Nitta, K., Yoshioka, K., Kuwahara, H., Yasuhara, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8969 · Cited by 128
Huang, X., Chuang, L. I. U., Kong, N., Xiao, Y., Yurdagul, A., Tabas, I. A., & Tao, W. (2022) · Nature Protocols · doi:10.1038/s41596-021-00665-4 · Cited by 126
Biomedical applications of mRNA nanomedicine
Xiong, Q., Lee, G. Y., Ding, J., Li, W., & Shi, J. (2018) · Nano Research · doi:10.1007/s12274-018-2146-1 · Cited by 125
Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
Alidori, S., Akhavein, N., Thorek, D. L. J., Behling, K., Romin, Y., Queen, D., Beattie, B. J., Manova-Todorova, K. O., Bergkvist, M., Scheinberg, D. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9647 · Cited by 126
Mou, Q., Ma, Y., Zhu, X., & Yan, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.037 · Cited by 126
Rational vaccinology with spherical nucleic acids
Wang, S., Qin, L., Yamankurt, G., Skakuj, K., Huang, Z. N., Chen, P., Dominguez, D., Lee, A., Zhang, B., & Mirkin, C. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902805116 · Cited by 124
Raftery, R. M., Walsh, D. P., Castaño, I. M., Heise, A., Duffy, G. P., Cryan, S., & O’Brien, F. J. (2016) · Advanced Materials · doi:10.1002/adma.201505088 · Cited by 123
Imaging-guided delivery of RNAi for anticancer treatment
Wang, J., Mi, P., Lin, G., Wáng, Y. X. J., Liu, G., & Chen, X. S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.008 · Cited by 123
Xie, Y., Kim, N. H., Nadithe, V., Schalk, D. L., Thakur, A. B., Kılıç, A., Lum, L. G., Bassett, D. J. P., & Merkel, O. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.029 · Cited by 125
Illien, F., Rodríguez, N., Amoura, M., Joliot, A., Manjula, P., Cribier, S., Burlina, F., & Sagan, S. (2016) · Scientific Reports · doi:10.1038/srep36938 · Cited by 128
Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents
Brock, D. J., Kondow-McConaghy, H. M., Hager, E. C., & Pellois, J. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00799 · Cited by 122
Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles
Choi, K. Y., Correa, S., Min, J., Li, J., Roy, S., Laccetti, K. H., Dreaden, E. C., Kong, S. M., Heo, R., Roh, Y. H., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900018 · Cited by 120
Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche
Krohn-Grimberghe, M., Mitchell, M. J., Schloss, M. J., Khan, O. F., Courties, G., Guimarães, P. P. G., Rohde, D., Cremer, S., Kowalski, P. S., Sun, Y., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00623-7 · Cited by 123
Self-citationRGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy
Sheikh, A., Md, S., & Kesharwani, P. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.028 · Cited by 119
A review on current status of antiviral siRNA
Qureshi, A., Tantray, V. G., Kirmani, A. R., & Ahangar, A. G. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1976 · Cited by 118
Egorov, E., Pieters, C., Korach-Rechtman, H., Shklover, J., & Schroeder, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00929-2 · Cited by 118
Chen, Y., Gu, H., Zhang, D. S., Fan, L., Liu, T., & Xia, W. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.003 · Cited by 117
Conjugated polymer nanomaterials for theranostics
Qian, C., Chen, Y., Feng, P., Xiao, X., Dong, M., Yu, J., Hu, Q., Shen, Q., & Gu, Z. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.42 · Cited by 117
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
Zhao, M., Wang, R., Yang, K., Jiang, Y., Peng, Y., Li, Y., Zhang, Z., Ding, J., & Shi, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.019 · Cited by 118
Advances and challenges in targeting IRF5, a key regulator of inflammation
Almuttaqi, H., & Udalova, I. A. (2018) · FEBS Journal · doi:10.1111/febs.14654 · Cited by 116
Redox‐Responsive Nanoparticle‐Mediated Systemic RNAi for Effective Cancer Therapy
Xu, X., Wu, J., Liu, S., Saw, P. E., Tao, W., Li, Y., Krygsman, L., Yegnasubramanian, S., Marzo, A. M. D., Shi, J., et al. (2018) · Small · doi:10.1002/smll.201802565 · Cited by 115
Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells
Zhang, L., Deng, S., Zhang, Y., Peng, Q., Li, H., Wang, P., Fu, X., Lei, X., Qin, A., & Yu, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201900772 · Cited by 115
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
Park, J., Park, J., Pei, Y., Xu, J., & Yeo, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.004 · Cited by 114
Engineered Hydrogels for Local and Sustained Delivery of RNA‐Interference Therapies
Wang, L. L., & Burdick, J. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201601041 · Cited by 114
Cross-Kingdom Small RNAs among Animals, Plants and Microbes
Zeng, J., Gupta, V. K., Jiang, Y., Yang, B. J., Gong, L., & Zhu, H. M. (2019) · Cells · doi:10.3390/cells8040371 · Cited by 119
Current RNA-based Therapeutics in Clinical Trials
Zhou, L., Qin, Z., Zhu, Y., He, Z., & Xu, T. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190719100526 · Cited by 118
Multicomponent Supramolecular Polymers as a Modular Platform for Intracellular Delivery
Bakker, M. H., Lee, C. C., Meijer, E. W., Dankers, P. Y. W., & Albertazzi, L. (2016) · ACS Nano · doi:10.1021/acsnano.5b05383 · Cited by 113
Dendrimers Show Promise for siRNA and microRNA Therapeutics
Dzmitruk, V., Apartsin, E. K., Ihnatsyeu-Kachan, A., Abashkin, V., Shcharbin, D., & Bryszewska, M. J. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030126 · Cited by 113
Systemic mRNA delivery to the lungs by functional polyester-based carriers
Yan, Y., Xiong, H., Zhang, X., Cheng, Q., & Siegwart, D. J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01356 · Cited by 111
Quantitating Endosomal Escape of a Library of Polymers for mRNA Delivery
Jiang, Y., Qiao, L., Wang, Y., Xu, E., Ho, A. S. L., Singh, P., Wang, Y., Jiang, Z., Yang, F., Tietjen, G. T., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04426 · Cited by 111
Zhu, X., Fang, C., Jia, H., Huang, Y., Cheng, C. H. K., Ko, C., Chen, Z., Wang, J., & Wáng, Y. X. J. (2014) · Nanoscale · doi:10.1039/c4nr03865g · Cited by 109
Steinbach-Rankins, J. M., Seo, Y.-E., & Saltzman, W. M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.029 · Cited by 111
Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles
Kaczmarek, J. C., Patel, A. K., Rhym, L. H., Palmiero, U. C., Bhat, B., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120966 · Cited by 110
Self-citationBiodegradable Amino-Ester Nanomaterials for Cas9 mRNA Delivery in Vitro and in Vivo
Zhang, X., Li, B., Luo, X., Zhao, W., Jiang, J., Zhang, C., Gao, M., Chen, X., & Dong, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08163 · Cited by 107
Chen, C., Posocco, P., Liu, X., Cheng, Q., Laurini, E., Zhou, J., Liu, C., Wang, Y., Tang, J., Col, V. D., et al. (2016) · Small · doi:10.1002/smll.201503866 · Cited by 109
Lipid Nanovesicles by Microfluidics: Manipulation, Synthesis, and Drug Delivery
Liu, C., Feng, Q., & Sun, J. (2018) · Advanced Materials · doi:10.1002/adma.201804788 · Cited by 107
Lipid nanocarriers for microRNA delivery
Scheideler, M., Vidaković, I., & Prassl, R. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.104837 · Cited by 111
Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
Weng, Y., Huang, Q., Li, C., Yang, Y., Wang, X., Yu, J., Huang, Y., & Liang, X. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.004 · Cited by 110
Hammel, M., Fan, Y., Sarode, A., Byrnes, A. E., Zang, N., Kou, P., Nagapudi, K., Leung, D., Hoogenraad, C. C., Chen, T., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01186 · Cited by 107
Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Xu, C., Zhang, H., Sun, C., Liu, Y., Shen, S., Yang, X., Zhu, Y., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.031 · Cited by 106
Fluorine-Doped Cationic Carbon Dots for Efficient Gene Delivery
Zuo, G., Xie, A., Pan, X., Su, T., Li, J., & Dong, W. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00521 · Cited by 108
Aptamer-Based Targeted Protein Degradation
Liu, Y., Qian, X., Ran, C., Li, L., Fu, T., Su, D., Xie, S., & Tan, W. (2023) · ACS Nano · doi:10.1021/acsnano.2c10379 · Cited by 110
Mendes, R. G. P. R., Fernandes, A. R., & Baptista, P. V. (2017) · Genes · doi:10.3390/genes8030094 · Cited by 105
Hao, J., Kós, P., Zhou, K., Miller, J. B., Xue, L., Yan, Y., Xiong, H., Elkassih, S. A., & Siegwart, D. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b03429 · Cited by 104
Sato, Y., Matsui, H., Yamamoto, N., Sato, R., Munakata, T., Kohara, M., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.044 · Cited by 104
Zhang, F., Zhao, L., Wang, S., Yang, J., Lu, G., Luo, N., Gao, X., Ma, G., Xie, H., & Wei, W. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703326 · Cited by 104
Tan, Z., Jiang, Y., Zhang, W., Karls, L., Lodge, T. P., & Reineke, T. M. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b06218 · Cited by 105
The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments
Sasso, J. M., Ambrose, B. J. B., Tenchov, R., Datta, R. S., Basel, M. T., DeLong, R. K., & Zhou, Q. A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00024 · Cited by 108
Cui, L., Nakano, K., Obchoei, S., Setoguchi, K., Matsumoto, M., Yamamoto, T., Obika, S., Shimada, K., & Hiraoka, N. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.050 · Cited by 103
Wang, J., Zhao, W., Zhang, Z., Liu, X., Xie, T., Wang, L., Xue, Y., & Zhang, Y. (2024) · Advanced Materials · doi:10.1002/adma.202308915 · Cited by 104
Jarzębińska, A., Pasewald, T., Lambrecht, J., Mykhaylyk, O., Kümmerling, L., Beck, P., Hasenpusch, G., Rudolph, C., Plank, C., & Dohmen, C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603648 · Cited by 101
Liu, X., Liu, C., Zhou, J., Chen, C., Qu, F., Rossi, J. J., Rocchi, P., & Peng, L. (2014) · Nanoscale · doi:10.1039/c4nr04759a · Cited by 106
Hörtz, C., Birke, A., Kaps, L., Decker, S., Wächtersbach, E., Fischer, K., Schuppan, D., Barz, M., & Schmidt, M. (2015) · Macromolecules · doi:10.1021/ma502497x · Cited by 101
Ding, F., Feng, J. C., Zhang, X., Sun, J., Fan, C., & Ge, Z. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.008 · Cited by 100
Muralidharan, R., Babu, A., Amreddy, N., Basalingappa, K. M., Mehta, M., Chen, A., Zhao, Y. D., Kompella, U. B., Munshi, A., & Ramesh, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0201-1 · Cited by 99
Yi, Y., Kim, H. J., Mi, P., Zheng, M., Takemoto, H., Toh, K., Kim, B. S., Hayashi, K., Naito, M., Matsumoto, Y., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.041 · Cited by 99
Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
Patel, S., Athirasala, A., Menezes, P. D. P., Ashwanikumar, N., Zou, T., Sahay, G., & Bertassoni, L. E. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0444 · Cited by 101
Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
Moss, K. H., Popova, P. G., Hadrup, S. R., Astakhova, K., & Taskova, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01290 · Cited by 101
Recent developments of RNA-based vaccines in cancer immunotherapy
Faghfuri, E., Pourfarzi, F., Faghfouri, A. H., Shadbad, M. A., Hajiasgharzadeh, K., & Baradaran, B. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1815704 · Cited by 100
Recent Advances in Nanoparticle-Based Cancer Treatment: A Review
Bajpai, S., Tiwary, S. K., Sonker, M., Joshi, A., Gupta, V., Kumar, Y., Shreyash, N., & Biswas, S. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00779 · Cited by 100
Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery
Sinegra, A. J., Evangelopoulos, M., Park, J., Huang, Z. N., & Mirkin, C. A. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01973 · Cited by 100
‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Fu, L., Zhang, Y., Farokhzad, R. A., Mendes, B. B., Conde, J., & Shi, J. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00998f · Cited by 100
Smart hydrogel: A new platform for cancer therapy
Li, G., Fu, Z.-M., Li, H., Wei, R., Guo, J., Wang, H., & Qi, J. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103470 · Cited by 100
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
Jarrett, K. E., Lee, C. M., Yeh, Y.-H., Hsu, R. H., Gupta, R., Zhang, M., Rodriguez, P. J., Lee, C. S., Gillard, B. K., Bissig, K., et al. (2017) · Scientific Reports · doi:10.1038/srep44624 · Cited by 100
Research progress of microneedles in the treatment of melanoma
Li, X., Zhao, Z., Zhang, M., Ling, G., & Zhang, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.021 · Cited by 99
Metadata
- Authors
- Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Boston Children's Hospital (US)
- Corresponding author
- Anderson, Daniel
- Venue
- Nature Materials
- Published
- 2013-10-23
- Volume
- 12
- Issue
- 11
- Pages
- 967-977
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W1995770815
- Cited by
- 1,800
- References
- 113
- Citations by year
- 2026: 77 · 2025: 103 · 2024: 111 · 2023: 138 · 2022: 139 · 2021: 148 · 2020: 159 · 2019: 129 · 2018: 164 · 2017: 151 · 2016: 183 · 2015: 179 · 2014: 114 · 2013: 4
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Materials (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- siRNA delivery, RNA interference therapy, lipid nanoparticles, siRNA conjugates, gene silencing, drug delivery materials
- MeSH terms
- Animals, Drug Carriers, Humans, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review